Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
#stockmarket #breaking
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance – CNBC
